Home/Pipeline/OpenCRISPR

OpenCRISPR

Gene Editing Platform

Research/Pre-clinicalActive

Key Facts

Indication
Gene Editing Platform
Phase
Research/Pre-clinical
Status
Active
Company

About Profluent

Profluent is an AI-first protein design company pioneering the use of large language models and other foundation AI models to generate and optimize novel protein sequences. The company integrates its computational platform with an in-house wet lab to experimentally validate designs, creating a closed-loop system for developing proteins with desired functions. Its initial proof-of-concept, OpenCRISPR, demonstrates the platform's ability to design complex gene-editing systems, positioning Profluent at the intersection of generative AI and synthetic biology. The company operates as a platform technology provider, partnering with other entities to apply its AI to diverse challenges in medicine and beyond.

View full company profile